Author

W T Beck

Observed name: W.T. Beck

Institution: Indiana University Bloomington

Observed institutions: St. Jude Children's Research Hospital, Indiana University Bloomington

OpenAlex ID: A5025376802

Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.

1996 · E G Schuetz, W T Beck, et al. · Molecular Pharmacology · 492

A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.

1995 · U G Bhat, M A Winter, et al. · Molecular Pharmacology · 34

Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil

1986 · W.T. Beck, M.C. Cirtain, et al. · Journal of Ethnopharmacology · 14

Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell lines.

1986 · W T Beck, M K Danks, et al. · PubMed · 5

Quantitation of mitoxantrone accumulation, efflux and modulation in MDR human MDA-MB-435 cancer cells

2005 · Fei Shen, Exing Wang, et al. · Cancer Research · 1

Modulation of multiple drug resistance mdr in cem vlb 100 cells structure activity relationships in a series of 100 reserpine analogs

1988 · Homer L. Pearce, Nicholas J. Bach, et al. · Proceedings of the American Association for Cancer Research Annual Meeting · 1

Molecular pharmacology of reversal of multidrug resistance

1994 · W T Beck · Anti-Cancer Drugs

Works count: 7

Citation count: 547

H-index: 4

I10-index: 3